TrialInternational urology and nephrology2018

Antiplatelet (aspirin) therapy as a new option in the treatment of vasculogenic erectile dysfunction: a prospective randomized double-blind placebo-controlled study.

Zeki Bayraktar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.